Teva Pharmaceutical Industries Ltd
TEVA20.460USD
-0.060-0.29%
Handelsschluss 11/04, 16:00（ET）Kurse um 15 Minuten verzögert
23.47BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Teva Pharmaceutical Industries Ltd Unternehmen
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd Informationen
BörsenkürzelTEVA
Name des UnternehmensTeva Pharmaceutical Industries Ltd
IPO-datumJan 01, 1951
CEOMr. Richard D. Francis
Anzahl der mitarbeiter33892
WertpapierartOrdinary Share
GeschäftsjahresendeJan 01
Addresse124 Dvora Hanevi'a St.
StadtTEL AVIV-YAFO
BörseTel Aviv Stock Exchange
LandIsrael
Postleitzahl6944020
Telefon97239148213
Websitehttps://www.tevapharm.com/
BörsenkürzelTEVA
IPO-datumJan 01, 1951
CEOMr. Richard D. Francis
Führungskräfte von Teva Pharmaceutical Industries Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
Andere
501.00M
12.00%
Nach RegionUSD
Name
Umsatz
Anteil
United States
2.15B
51.51%
Europe
1.30B
31.06%
International Markets
495.00M
11.85%
Other
232.00M
5.56%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
Andere
501.00M
12.00%
Aktionärsstatistik
Aktualisiert: Tue, Nov 4
Aktualisiert: Tue, Nov 4
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Menora Mivtachim Insurance Ltd.
5.00%
Fidelity Management & Research Company LLC
4.41%
Phoenix Investment and Finances Ltd
3.60%
Ion Asset Management Israel Ltd
3.34%
Harel Insurance Investments and Financial Services Ltd
3.29%
Andere
80.35%
Aktionäre
Aktionäre
Anteil
Menora Mivtachim Insurance Ltd.
5.00%
Fidelity Management & Research Company LLC
4.41%
Phoenix Investment and Finances Ltd
3.60%
Ion Asset Management Israel Ltd
3.34%
Harel Insurance Investments and Financial Services Ltd
3.29%
Andere
80.35%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
25.80%
Hedge Fund
13.29%
Investment Advisor/Hedge Fund
11.28%
Insurance Company
7.85%
Research Firm
2.46%
Pension Fund
1.90%
Family Office
1.42%
Bank and Trust
0.90%
Sovereign Wealth Fund
0.24%
Andere
34.85%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Menora Mivtachim Insurance Ltd.
57.40M
5%
+18.90M
+49.10%
Jul 16, 2025
Fidelity Management & Research Company LLC
50.63M
4.41%
-24.67M
-32.76%
Jun 30, 2025
Phoenix Investment and Finances Ltd
37.76M
3.29%
+10.30M
+37.49%
Jun 30, 2025
Ion Asset Management Israel Ltd
38.35M
3.34%
-685.63K
-1.76%
Jun 30, 2025
Harel Insurance Investments and Financial Services Ltd
33.39M
2.91%
+11.33M
+51.39%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
33.89M
2.95%
+833.03K
+2.52%
Jun 30, 2025
Migdal Insurance and Financial Holdings Ltd
28.69M
2.5%
+2.35M
+8.92%
Jun 30, 2025
Clal Insurance Enterprises Holdings Ltd.
32.36M
2.82%
-5.43M
-14.37%
Jun 30, 2025
Lingotto Investment Management LLP
28.16M
2.45%
+302.98K
+1.09%
Jun 30, 2025
Rubric Capital Management LP
26.00M
2.27%
+450.00K
+1.76%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Mon, Oct 6
Aktualisiert: Mon, Oct 6
Name
Anteil
VanEck Israel ETF
7.07%
iShares MSCI Israel ETF
6.66%
ARK Israel Innovative Technology ETF
1.9%
VanEck Pharmaceutical ETF
1.73%
WealthTrust DBS Long Term Growth ETF
1.36%
WisdomTree International Multifactor Fund
0.59%
iShares Health Innovation Active ETF
0.5%
iShares MSCI Intl Value Factor ETF
0.41%
iShares MSCI EAFE Value ETF
0.14%
DFA Dimensional Internatl High Profitability ETF
0.12%
Mehr Anzeigen
VanEck Israel ETF
Anteil7.07%
iShares MSCI Israel ETF
Anteil6.66%
ARK Israel Innovative Technology ETF
Anteil1.9%
VanEck Pharmaceutical ETF
Anteil1.73%
WealthTrust DBS Long Term Growth ETF
Anteil1.36%
WisdomTree International Multifactor Fund
Anteil0.59%
iShares Health Innovation Active ETF
Anteil0.5%
iShares MSCI Intl Value Factor ETF
Anteil0.41%
iShares MSCI EAFE Value ETF
Anteil0.14%
DFA Dimensional Internatl High Profitability ETF
Anteil0.12%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
